MTVA MetaVia Inc.
Company Analysis
Latest News
🟢 MetaVia is trading 5.6% up today amid a broad tech and software rally
MetaVia is trading at $1.50, up 5.6% today, bouncing from recent weakness amid a broad rally in software and technology names. • The software sector is up...
🟢 MetaVia is trading 6.8% up today amid small-cap volatility
MetaVia is trading at $1.61 (+6.76%) in pre-market action, rebounding from a weak prior session despite the absence of any visible company-specific...
🔴 MetaVia is trading 11.9% down today amid technical selling and sector uncertainty
MetaVia is trading 11.9% down at $1.48 amid continued technical and sentiment-driven selling following prior financing-related volatility. - The move occurs...
🟢 MetaVia is trading 6.1% up today as it rebounds from recent sector pressure
MetaVia is trading at $1.81 (6.1% up) in pre-market, rebounding from last week’s tech-led selloff and several consecutive weak sessions. • The move appears to...
🔴 MetaVia is trading 5.6% down today amid continued selling pressure and broad tech weakness
MetaVia is trading at $1.70 (5.6% down) following a weak open and continued pressure from the prior session's decline. • No company-specific catalysts have...
🔴 MetaVia is trading 6.7% down today as obesity drug rally cools and profit-taking continues
MetaVia is trading at $1.80, down 6.7% in pre-market, extending a pullback that began after profit-taking on July 14, 2026. • The stock has experienced...
🔴 MetaVia is trading 7.5% down today as traders take profits following a surge on obesity drug trial progress
MetaVia is trading 7.5% down at $1.94 as investors lock in gains following a sharp rally driven by optimism surrounding its DA-1726 obesity drug trial...
🔴 MetaVia is trading 10.5% down
MetaVia is trading at $1.78, down 10.5% from a comparison close of $1.99 during pre-market. This is a price-action follow-up, so a separate catalyst may not be...
MetaVia's Obesity Drug Hype Meets Gravity: Can a $1.81 Stock Hold Its Gains Without Fresh Catalysts?
Shares of MetaVia Inc. (MTVA) slid 9.2% to $1.81 on Monday as traders locked in profits from a blistering rally that had pushed the micro-cap biotech up...
🔴 MetaVia is trading 9.2% down today after a sharp rally and profit-taking
MetaVia is trading at $1.81 (9.2% down) as investors lock in gains following a significant multi-day rally and signs of profit-taking. • The stock recently...
🔴 MetaVia is trading 6.5% down today on profit-taking after recent gains
MetaVia is trading at $1.86 (6.5% down) in after-hours trading as the stock pulls back following a period of significant upward momentum. • The decline...
🟢 MetaVia is trading 10.1% up
MetaVia is trading at $1.96, up 10.1% from a comparison close of $1.78 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
🟢 MetaVia is trading 5% up today on continued momentum for its obesity and cardiometabolic drug programs
MetaVia is trading 5% up at $1.87 amid continued interest in its obesity and cardiometabolic drug programs. • Recent gains follow late-breaking abstract...
🟢 MetaVia is trading 10.1% up
MetaVia is trading at $1.72, up 10.1% from a comparison close of $1.56 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
🟢 MetaVia Soars 5.1% After Announcing Completion of Dose Titration in Phase 1 Part 3 Obesity Study
• MetaVia Inc. (MTVA) shares are up 5.1% today, trading at $1.64. • The company announced successful completion of dose titration for all active patients in...
🔴 MTVA is trading 5.1% down today on profit-taking after a multi-day bounce
MTVA is trading at $1.50 (down 5.1%) as the stock pulls back following a strong multi-day rally that saw shares close at $1.58 on July 07, 2026. • The decline...
🟢 MTVA is trading 6.62% up today with no clear company-specific catalyst
MTVA is trading at $1.61 (6.62%) up today despite a lack of clearly identified company-specific news or catalysts in available sources. • The stock is...
MetaVia expands stock offering to $4 million, seeking major capital boost
MetaVia Inc. increased its at-the-market equity program to allow for the sale of up to $4 million in common stock. The clinical-stage biotechnology company...
🔴 MTVA is trading 5.4% down today as shares pull back from a short-term rebound
MTVA is trading 5.4% down at $1.41 as shares pull back from a short-term rebound. • The decline appears to be driven by normal volatility and profit-taking...
🔴 MTVA is trading 6.5% down today as it pulls back from a recent rebound
MTVA is trading 6.5% down at $1.39 in thin pre-market activity, pulling back after a recent rebound that saw the stock close at $1.49 on June 29. • There are...